Pfizer says COVID pill is effective against omicron

News

FILE – The Pfizer logo is displayed at the company’s headquarters, Feb. 5, 2021, in New York. Pfizer is spending $6.7 billion to buy a drugmaker with no products on the market and a focus on developing treatments for inflammatory conditions like Chrohn’s disease. The pharmaceutical giant said Monday, Dec. 13, 2021 it will pay $100 in cash for each share of Arena Pharmaceuticals in a deal already approved by the boards of both companies.(AP Photo/Mark Lennihan, File)

WASHINGTON (AP) — Pfizer says that its experimental COVID-19 pill appears effective against the omicron variant.

The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths.

The updates come as U.S. regulators are expected to soon decide on whether to authorize Pfizer’s pill and a competing drug from Merck.

If authorized, the pills would be the first COVID-19 drugs that Americans could take at home to treat the virus.

Pfizer is seeking U.S. authorization for high-risk adults but is also studying the drug in lower-risk adults.

The company said the drug missed a key study goal in ongoing testing of those patients.

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trademark and Copyright 2022 The Associated Press. All rights reserved.

FOX 8 Cleveland Weather // Quick Links:

Hot on FOX 8

More Viral